Filing Details
- Accession Number:
- 0001209191-21-004341
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-01-20 16:51:19
- Reporting Period:
- 2021-01-15
- Accepted Time:
- 2021-01-20 16:51:19
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1294133 | Inogen Inc | INGN | Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1596080 | Alison Bauerlein | C/O Inogen, Inc. 326 Bollay Drive Goleta CA 93117 | Evp, Finance, & Cfo | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-01-15 | 18,098 | $16.62 | 20,413 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-01-15 | 15,966 | $44.28 | 4,447 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-01-15 | 2,132 | $44.83 | 2,315 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2021-01-15 | 18,098 | $0.00 | 18,098 | $16.62 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 36,196 | 2021-03-31 | No | 4 | M | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 11, 2020.
- Represents the weighted average share price of an aggregate total of 15,966 shares sold in the price range of $43.71 to $44.69 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- Represents the weighted average share price of an aggregate total of 2,132 shares sold in the price range of $44.75 to $45.215 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- Subject to the reporting person's continuing service, 1/48th of the total shares subject to the option shall vest every month after March 1, 2014.
- Form 4 filed on 04/02/2014 indicated an incorrect expiration date.
- Previously filed form 4 incorrectly listed the number of derivative securities beneficially owned as 0.
Billionaire Hedge Funds
